Correlation Between HUTCHMED DRC and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Aquestive Therapeutics, you can compare the effects of market volatilities on HUTCHMED DRC and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Aquestive Therapeutics.
Diversification Opportunities for HUTCHMED DRC and Aquestive Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between HUTCHMED and Aquestive is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Aquestive Therapeutics
Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 0.7 times more return on investment than Aquestive Therapeutics. However, HUTCHMED DRC is 1.44 times less risky than Aquestive Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 1,800 in HUTCHMED DRC on September 1, 2024 and sell it today you would lose (105.00) from holding HUTCHMED DRC or give up 5.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
HUTCHMED DRC vs. Aquestive Therapeutics
Performance |
| Timeline |
| HUTCHMED DRC |
| Aquestive Therapeutics |
HUTCHMED DRC and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HUTCHMED DRC and Aquestive Therapeutics
The main advantage of trading using opposite HUTCHMED DRC and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| HUTCHMED DRC vs. Crinetics Pharmaceuticals | HUTCHMED DRC vs. Enanta Pharmaceuticals | HUTCHMED DRC vs. Amicus Therapeutics | HUTCHMED DRC vs. Connect Biopharma Holdings |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |